Table 5 Prevalence of substance use at baseline for all clients, and comparisons of baseline and follow-up substance use for individuals available for follow up (n = 47)
Substances | Baseline, all clients N = 92 | Baseline of those assessed at FU n = 47 (%) | Follow-up n = 47 (%) | p |
|---|---|---|---|---|
Alcohol | 45 (48.9%) | 16 (34.0%) | 5 (10.6%) | .006 |
Heroin | 31 (33.7%) | 15 (31.9%) | 6 (12.8%) | .026 |
Crack or powder cocaine | 60 (65.2%) | 30 (63.8%) | 9 (19.1%) | <.0001 |
Illicit methadone | 5 (5.4%) | 4 (8.5%) | 1 (2.1%) | .168 |
Illicit benzodiazepines | 14 (15.2%) | 7 (14.9%) | 3 (6.4%) | .181 |
Amphetamine | 12 (13.0%) | 7 (14.9%) | 3 (6.4%) | .181 |
Injection Drug Use | 32 (34.8%) | - | - | |
Sharing syringes | 2 (2.2%) | - | - |